SCHEMBL12499028

SCHEMBL12499028

COc1ccc(S(=O)(=O)NCCCl)cc1

nearest known ligand 0.75

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.75
▸ PKM P14618 1/20 0.75
▸ SMN1; SMN2 Q16637 2/20 0.69
▸ POLB P06746 2/20 0.63
▸ MEN1 O00255 1/20 0.61
▸ KMT2A Q03164 1/20 0.61
▸ USP2 O75604 1/20 0.60
▸ CYP19A1 P11511 1/20 0.56
▸ CA1 P00915 1/20 0.56
▸ CA2 P00918 1/20 0.56
▸ MMP1 P03956 1/20 0.56
▸ MMP2 P08253 1/20 0.56
▸ MMP9 P14780 1/20 0.56
▸ MMP8 P22894 1/20 0.56
▸ MMP13 P45452 1/20 0.56
▸ MEP1B Q16820 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ HTR7 P34969 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8574072 0.90 ALDH1A1 (0.81) ALDH1A1PKMSMN1; SMN2POLBMEN1
SCHEMBL5563528 0.89 ALDH1A1 (0.86) ALDH1A1PKMSMN1; SMN2POLBMEN1
SCHEMBL29183277 0.87 ALDH1A1 (0.82) ALDH1A1PKMSMN1; SMN2POLBMEN1
SCHEMBL5770948 0.84 ALDH1A1 (0.77) ALDH1A1PKMSMN1; SMN2POLBMEN1
SCHEMBL31014207 0.83 ALDH1A1 (0.75) ALDH1A1PKMSMN1; SMN2POLBMEN1
SCHEMBL6379743 0.83 ALDH1A1 (0.75) ALDH1A1PKMSMN1; SMN2POLBMEN1
SCHEMBL6100066 0.83 ALDH1A1 (0.75) ALDH1A1PKMSMN1; SMN2POLBMEN1
SCHEMBL15145873 0.83 ALDH1A1 (0.75) ALDH1A1PKMSMN1; SMN2POLBMEN1
SCHEMBL26212922 0.82 ALDH1A1 (0.51) ALDH1A1PKMSMN1; SMN2POLBMEN1
SCHEMBL7113122 0.81 ALDH1A1 (1.00) ALDH1A1PKMSMN1; SMN2POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012101648-A1 NOVEL PROCESS FOR THE SYNTHESIS OF ENANTIOMERICALLY PURE 2-METHOXY-5-[(2R)-2-(4-ALKYLPIPERAZIN-L-YL)PROPYL]-BENZENESULFONAMIDE HAVALDAR FREDDY H 2012-08-02 — — WO claimed
CN-117209453-A Preparation and application of levocetirizine hydrochloride intermediate 迪嘉药业集团股份有限公司 2023-12-12 — — CN disclosed
Send feedback